# P2-COMPANION-6 — After-Visit Continuity — CLOSED

Date: 2026-08-13

## Status

P2-COMPANION-6 is closed as a governed runtime lot.

## Certified authority

The After-Visit Continuity capability records an explicit consultation anchor and structured after-visit facts, then projects them deterministically into the certified companion contract.

It MUST NOT:
- infer that a consultation occurred from glucose logs, app activity, treatment profile or model output;
- infer treatment efficacy, diagnosis, causality, prediction, urgency, prescription, dose advice or treatment optimization/change from temporal association;
- collapse patient-recorded, clinician-recorded and governed-derived facts into one undifferentiated truth class;
- grant autonomous clinical authority to a generative model.

It DOES:
- persist `AfterVisitAnchor` and `AfterVisitFactRecord`;
- constrain anchor source and fact kind at the database boundary;
- require evidence IDs for governed derivations;
- prevent facts from predating the explicit consultation anchor;
- serialize writes through the shared patient-row lock;
- project only structured persisted facts into the bounded After-Visit contract;
- preserve the limitation `temporal_association_is_not_treatment_efficacy`;
- delete persisted After-Visit rows through the user foreign-key cascade, regression-tested in the runtime lot.

## Evidence

Contract foundation:
- PR #157
- merge: `3d11f5453ea4ea9e4fedea2c0c1d4d1d85d1bb4b`
- post-merge CI #1950: SUCCESS
- post-merge migration drift #1762: SUCCESS

Runtime:
- PR #158
- exact head: `e59f9e09a3facc8192a5293341e7685f42a0b461`
- changed files: 5
- exact-head CI #1952: SUCCESS
- exact-head migration drift #1764: SUCCESS
- Database/Migration Review: PASS
- Clinical Safety Review: PASS
- Release Certifier: GO
- zero unresolved review threads at release gate
- expected-head merge: `1c66ce84d549ba2a7d78bd8e07cc1135ccb45049`
- post-merge CI #1953: SUCCESS
- post-merge migration drift #1765: SUCCESS

## Remaining product scope

This closeout does not certify a patient-facing Companion UX. No endpoint or Flutter surface was added by the runtime lot.

## Next

P2-COMPANION-7 — Companion UX is NEXT.

The UX must remain patient-first and expose the existing governed companion loop without virtual-doctor framing:

`UNDERSTAND → FOLLOW → PREPARE`

P2-COMPANION-8 remains the final Safety + Certification lot after the UX work.
